LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Patch Painlessly Tests for Glucose in Diabetics

By LabMedica International staff writers
Posted on 05 May 2009
A skin patch could one day provide a less-invasive alternative for diabetics who need to take regular samples of their own blood to keep glucose levels in check.

The patch, approximately the size of a deck of cards, contains four micro-needles that "bite" sequentially at programmed intervals. The needles are electronically controlled to penetrate the skin deep enough to draw blood from a capillary, but not deep enough to hit a nerve. This means patients would experience little or no pain. The patch could be worn anywhere on the body where it could obtain accurate readings of capillary blood.

Electrical engineers from the Schulich School of Engineering at the University of Calgary (Alberta, Canada) have patented the device, which they dubbed the Electronic Mosquito. A sensor in each cell of the e-Mosquito measures sugar levels in the blood. These data can then be sent wirelessly to a remote device such as a computer or a monitoring instrument worn on the wrist. The system could even be connected to an alarm to alert patients or doctors when blood sugar levels enter the danger zone. The currently used method of drawing blood from fingertips and using glucose-testing strips can be painful, inconvenient, and time-consuming.

"This is a dramatic improvement over manual poking, particularly for children and elderly patients," said Martin Mintchev, director of the Low Frequency Instrumentation Lab at the Schulich School of Engineering. "Our approach is radically different and offers a reliable, repeatable solution with the minor inconvenience of wearing something similar to an adhesive bandage."

Eventually, the biomedical engineers intend to integrate a pump system so insulin injections can also become autonomous based on data from the e-Mosquito, thus converting the device into an external artificial pancreas.

Approximately 246 million people around the world are affected by diabetes. More than two million Canadians have diabetes, a number that is increasing because of the aging population and rising obesity rates, according to the Canadian Diabetes Association.

Related Links:
Schulich School of Engineering at the University of Calgary


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
ESR Analyzer
TEST1 2.0

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more